Mr. Kwon brings 13 years of biotech industry experience focused on business development and commercial strategy in oncology and has spent 11 years as a strategy consultant working with top biopharma companies. He was originally trained as a cancer biologist and has held positions as a Research Scientist at Memorial ... Read More

Mr. Ball serves as Aadi’s Chief Technical Operations Officer, bringing 25 years of experience leading quality, manufacturing and supply chain teams in healthcare regulated industries. Most recently, Mr. Ball served as the CQO and SVP Operations at Intercept Pharmaceuticals, where he oversaw commercial product and prepared the organization to support ... Read More

Mr. Rodin joined Aadi in February 2022 as SVP and General Counsel. He was most recently the Executive Vice President and General Counsel of The Medicines Company, which was acquired by Novartis for $9.7B in January 2020. During his 13-year tenure at The Medicines Company, Steve led or ... Read More

Prior to joining Aadi in 2021, Mr. Giacobello's background included fulfilling key financial and operational roles with a long history of leadership in commercial stage growth companies. He played a key role in the buildout of U.S. operations and commercial readiness in his role as CFO at GW Pharmaceuticals, leading ... Read More